Heart Regeneration Technologies

Achievements

The achievement of Heart Regeneration Technologies is to refine low-energy regenerative shockwave therapy. Shockwaves at low energy levels exert regenerative effects rather than disintegration of stones or plaques such as with high energies in Lithotripsie. We developed a sterile applicator suitable for direct cardiac application during heart surgery. Our hand-held applicator is the worlds smallest shockwave applicator and the treatment on the heart is highly differentiated from existing products.

Numerous small and large animal trials helped us to clarify the exact molecular working mechanism of the new technology and led us to a first in-men application. In this human pilot trial we have been able to confirm safety and feasibility of the new treatment.

Our results have been published in high-ranked scientific journals (e.g. Cardiovascular Research, JTCVS, PLoS One) and presented at major international meetings (e.g. ESC, AHA, EACTS).

We were awarded numerous national and international research as well as business plan prizes. Most recently, we made the 2nd place of the EACTS Techno College Innovation Award as being one of the three most important innovations in cardiac surgery in 2016!

View original post here:

Heart Regeneration Technologies